We came across a bullish thesis on Pfizer Inc. on Investing With Purpose’s Substack. In this article, we will summarize the bulls’ thesis on PFE. Pfizer Inc.'s share was trading at $24.15 as of September 18th. PFE’s trailing and forward P/E were 12.78 and 7.74 respectively according to Yahoo Finance.
[caption id="attachment_557899" align="aligncenter" width="750"]Pfizer (PFE) has experienced a sharp post-COVID revenue normalization, with sales retreating from a 2022 peak of ~$100 billion to $58 billion in 2023, though forecasts...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.